Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Arvid Sandforth
Prevention of type 2 diabetes through prediabetes remission without weight loss - Nature Medicine
Abstract Clinical practice guidelines recommend defined weight loss goals for the prevention of type 2 diabetes (T2D) in those individuals with increased risk, such as prediabetes. However, achieving prediabetes remission, that is, reaching normal glucose regulation according to American Diabetes Association criteria, is more efficient in preventing T2D than solely reaching weight loss goals.
Timing Matters in Prediabetes Remission, with Arvid Sandforth, MD
Achieving early remission of prediabetes to normal glucose regulation (NGR) during lifestyle intervention offered additional protective benefits for preventing type 2 diabetes (T2D) compared with late remission. These findings were presented at at the 2025 American Diabetes Association (ADA) Scientific Sessions, held June 20-23, in Chicago, Illinois, by primary investigator Arvid Sandforth, MD, physician scientist, Institute of Diabetes Research and Metabolic Diseases, Tübingen, Germany.
HCPLive Five at ADA Scientific Sessions 2025
The 2025 American Diabetes Association (ADA) Scientific Sessions, held June 20–23 in Chicago, reflected a shifting paradigm in diabetes care prioritizing comprehensive approaches to glucose management, cardiometabolic health, and patient-centered outcomes. This year’s meeting featured a diverse slate of groundbreaking research spanning automated insulin delivery, weekly insulin alternatives, and novel interventions tackling unique drivers of glycemic dysregulation.
Glycemic Control Trumps Weight Loss for Type 2 Diabetes Prevention, with Arvid Sandforth, MD
Sandforth emphasized the important of achieving prediabetes remission for preventing T2D as seen in his new research. New research posits that prediabetes remission based off of achieving glycemic targets should be the primary treatment goal for type 2 diabetes (T2D) prevention, rather than weight loss targets.
Prediabetes remission to reduce the global burden of type 2 diabetes
Pathophysiology and natural history of prediabetes Once prediabetes develops, glucose homeostasis is already strongly, but partly still reversibly, dysregulated. Its pathophysiology seems to be to some extent specific to the individual at-risk condition, including BMI category, body composition, and genetic risk.
Role of Weight Loss Induced Prediabetes Remission in the Prevention of Type 2 Diabetes - Time to Improve Diabetes Prevention
ALB received lecture / advisory board fees from Bayer; lecture fees from NovoNordisk, Boehringer Ingelheim, Daiichi Sankyo, Lilly paid to University Hospital Tübingen: ALB is co-founder of Eternygen GmbH The analysis for this paper was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). DPP was supported by NIDDK and other agencies.
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)
1. US Centers for Disease Control and Prevention National Diabetes Statistics Report. 2. Rooney MR Fang M Ogurtsova K et al. Global prevalence of prediabetes. Diabetes Care. 2023; 46: 1388-1394 3. ElSayed NA Aleppo G Aroda VR et al. Classification and diagnosis of diabetes: standards of care in diabetes—2023. Diabetes Care. 2023; 46: S19-S40 4. Ligthart S van Herpt TTW Leening MJG et al.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Arvid
Contact Arvid, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack